Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 3/2000

01-05-2000 | ORIGINAL ARTICLE

Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-γ-transfected glioma cells

Authors: Edward Visse, Anna C. M. Johansson, Bengt Widegren, Hans Olov Sjögren, Peter Siesjö

Published in: Cancer Immunology, Immunotherapy | Issue 3/2000

Login to get access
Metadata
Title
Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-γ-transfected glioma cells
Authors
Edward Visse
Anna C. M. Johansson
Bengt Widegren
Hans Olov Sjögren
Peter Siesjö
Publication date
01-05-2000
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620050613

Other articles of this Issue 3/2000

Cancer Immunology, Immunotherapy 3/2000 Go to the issue

ORIGINAL ARTICLE

Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells

ORIGINAL ARTICLE

Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia

ORIGINAL ARTICLE

Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice

POINT AND COUNTERPOINT

Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine

ORIGINAL ARTICLE

Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody

POINT AND COUNTERPOINT

Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits